companydata.dkcompanydata.dk

Jan Møller Mikkelsen

PersonUnit number: 4000541773
543 Seale avenue Palo Alto CA 94301(United States)
1
Ownership
15
Board positions
10
Director positions
3
Other roles
76
People in network

People in network(76)

People who held roles at the same companies, or who co-own the same companies

Michael Wolff Jensen
Ascendis Pharma Oncology Division A/S, ASCENDIS PHARMA A/S, ASCENDIS PHARMA A/S, Ascendis Pharma Europe A/S, ASCENDIS PHARMA BONE DISEASES A/S, Ascendis Pharma Growth Disorders A/S, Ascendis Pharma Endocrinology Division A/S, Ascendis Pharma Nordics A/S, VELOXIS PHARMACEUTICALS A/S, ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S
Anni Lotte Kirstine Pedersen
Ascendis Pharma Oncology Division A/S, ASCENDIS PHARMA A/S, Ascendis Pharma Europe A/S, ASCENDIS PHARMA BONE DISEASES A/S, Ascendis Pharma Growth Disorders A/S, Ascendis Pharma Endocrinology Division A/S, Ascendis Pharma Nordics A/S, ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S
Christian Karsten Hansen
MAXYGEN ApS, PROFOUND INVEST A/S, PROFOUND INVEST A/S, HYSCITE DISCOVERY A/S, NORDIC BIOTECH INCENTIVE ApS

Ownership(1)

CADENZA PARTNERS ApS
CVR: 25506014
EJERREGISTER
100%
Ownership
Active

Board positions(7)

Ascendis Pharma Oncology Division A/S
CVR: 41034076
BESTYRELSESMEDLEM
Active
Since 13. dec. 2019
ASCENDIS PHARMA A/S
CVR: 29918791
BESTYRELSESMEDLEM
Active
Since 11. dec. 2007
Ascendis Pharma Europe A/S
CVR: 44420449
BESTYRELSESMEDLEM
Active
Since 6. nov. 2023
ASCENDIS PHARMA BONE DISEASES A/S
CVR: 32323596
BESTYRELSESMEDLEM
Active
Since 29. jun. 2012
Ascendis Pharma Growth Disorders A/S
CVR: 32323677
BESTYRELSESMEDLEM
Active
Since 29. jun. 2012
Ascendis Pharma Endocrinology Division A/S
CVR: 32323537
BESTYRELSESMEDLEM
Active
Since 29. jun. 2012
ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S
CVR: 32323502
BESTYRELSESMEDLEM
Active
Since 29. jun. 2012

Director positions(7)

Active
Since 13. dec. 2019
ASCENDIS PHARMA A/S
CVR: 29918791
ADM. DIR.
Active
Since 27. nov. 2007
ASCENDIS PHARMA BONE DISEASES A/S
CVR: 32323596
ADM. DIR.
Active
Since 29. jun. 2012
Active
Since 29. jun. 2012
CADENZA PARTNERS ApS
CVR: 25506014
ADM. DIR.
Active
Since 21. jan. 2019
Active
Since 29. jun. 2012
Active
Since 29. jun. 2012

Other roles(2)

ASCENDIS PHARMA A/S
CVR: 29918791
STIFTERE
Active
Since 21. sep. 2006
Tobias Mikkelsen
CVR: 29024839
INTERESSENTER
Active
Since 10. okt. 2005

Indirect ownership(2)

Companies owned indirectly through ownership chains.

10-14,99%
Effective ownership
Depth: 1
Ownership path:
CADENZA PARTNERS ApS(100%)
→NORDIC BIOTECH INCENTIVE ApS(10-14,99%)
5-9,99%
Effective ownership
Depth: 1
Ownership path:
CADENZA PARTNERS ApS(100%)
→NORDIC BIOTECH PRIVATE INVESTORS ApS(5-9,99%)

Former board positions(8)

PROFOUND INVEST A/S
CVR: 25609964
BESTYRELSE
Dissolved
Ended
Since 8. feb. 2001
Until 26. nov. 2009
PROFOUND INVEST A/S
CVR: 25609964
DIREKTION
Dissolved
Ended
Since 19. okt. 2000
Until 26. nov. 2009
7TM A/S
CVR: 25108523
SUPPLEANT
Dissolved
Ended
Since 1. okt. 2001
Until 31. mar. 2006
NUEVOLUTION A/S
CVR: 26029708
BESTYRELSESMEDLEM
Ended
Since 28. nov. 2001
Until 14. mar. 2002
HYSCITE DISCOVERY A/S
CVR: 26976731
formand
Dissolved
Ended
Since 2. okt. 2003
Until 4. maj 2005
NEURONICON ApS
CVR: 26988179
formand
Dissolved
Ended
Since 26. okt. 2006
Until 27. jul. 2015
MAXYGEN ApS
CVR: 21637289
DIREKTION
Dissolved
Ended
Since 19. apr. 1999
Until 28. apr. 1999
Ascendis Pharma Nordics A/S
CVR: 44363437
BESTYRELSESMEDLEM
Dissolved
Ended
Since 5. okt. 2023
Until 5. dec. 2024

Former director positions(3)

CADENZA PARTNERS ApS
CVR: 25506014
DIREKTØR
Ended
Since 10. aug. 2000
Until 29. nov. 2018
Ascendis Pharma Nordics A/S
CVR: 44363437
ADM. DIR.
Dissolved
Ended
Since 5. okt. 2023
Until 5. dec. 2024
VELOXIS PHARMACEUTICALS A/S
CVR: 26527767
ADM. DIR.
Ended
Since 1. jan. 2003
Until 7. sep. 2006

Former roles(1)

NORDIC BIOTECH INCENTIVE ApS
CVR: 26277779
STIFTERE
Ended
Since 3. okt. 2001
Until 19. okt. 2001